论文部分内容阅读
急性出血性脑血管病(acute hemorrhagic cerebrovasculardisease,AHCVD)是一种严重影响中老年人健康的疾病,易导致死亡和重残。AHCVD发病后机体免疫功能变化的研究报道较少。我们对43例脑出血患者血T细胞亚群及血清IL-2、可溶性白细胞介素-2受体(sIL-2R)水平变化进行了检测,目的在于探讨AHCVD患者免疫功能状态及其临床意义,进而为阐明AHCVD的发病机制、病程演变提供线索,并为AHCVD的治疗提供一定的依据。
Acute hemorrhagic cerebrovascular disease (AHCVD) is a disease that seriously affects the health of middle-aged and elderly people, which can easily lead to death and severe disability. AHCVD after the onset of immune function changes reported less. We tested the changes of serum T-lymphocyte subsets, serum IL-2 and soluble interleukin-2 receptor (sIL-2R) in 43 patients with intracerebral hemorrhage in order to investigate the immune status and clinical significance of AHCVD patients, In order to elucidate the pathogenesis of AHCVD, provide clues for the course of disease evolution, and provide a basis for the treatment of AHCVD.